“When patients have a flare-up of Crohn’s, they can have anemia,” says William Sandborn, MD, the chief of gastroenterology and the director of the inflammatory bowel disease center at the ...
In a joint study, Prof. Dirk Haller and Dr. Tobias Schwerd demonstrated how the gut microbiome changes during nutritional therapy. Prof. Dr. Dirk Haller (left) is a professor of nutrition and ...
The company is currently preparing for Phase III trials to further assess the efficacy and safety of the agent in identifying ...
Crohn s disease is a chronic inflammatory disease of the gastrointestinal tract, mostly affecting the ileum. The inflammation can extend through the intestinal wall and tends to be asymmetric and ...
Women who have symptoms such as bloating, bowel changes, appetite changes, or abdominal pain should be prioritised for a ...
In addition to conventional treatments, some people may use complementary and alternative medicine (CAM) to help manage Crohn’s disease symptoms. This can include the use of essential oils.
0:53 UBC researchers report breakthrough in Huntington treatment Scientists are unravelling the mystery of what triggers Huntington’s disease, a devastating and fatal hereditary disorder that ...
Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical trial has demonstrated the potential of focused ultrasound to safely ...
Jan. 16, 2025 – The FDA has approved the drug Omvoh for treating adults with moderately to severely active Crohn's disease, a type of chronic inflammatory bowel disease. This marks the second ...
Visible healing of the intestinal lining was observed in 46% of subjects treated with the therapy. Credit: SewCreamStudio/Shutterstock. Eli Lilly has received ...
Video: Broad Institute of MIT and Harvard At a glance: Study explains long-standing question of why Huntington’s disease symptoms typically do not appear until midlife even though patients are born ...
The FDA approved Eli Lilly’s Omvoh in Crohn’s disease, the company announced Wednesday, handing the drug its second indication after giving it a green light … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback